These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37853099)

  • 1. Trans - Perineal laser ablation of the prostate in high surgical risk patients affected by severe lower urinary tract symptoms related to benign prostatic obstruction.
    Destefanis P; Sibona M; Vitiello F; Vercelli E; Micai L; Montefusco G; Mangione C; Bracco F; Colucci F; De Nunzio C; Gontero P
    Prostate Cancer Prostatic Dis; 2023 Oct; ():. PubMed ID: 37853099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction.
    de Rienzo G; Lorusso A; Minafra P; Zingarelli M; Papapicco G; Lucarelli G; Battaglia M; Ditonno P
    Eur Urol; 2021 Jul; 80(1):95-103. PubMed ID: 32868137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ejaculatory function following transperineal laser ablation vs TURP for benign prostatic obstruction: a randomized trial.
    Bertolo R; Iacovelli V; Cipriani C; Carilli M; Vittori M; Antonucci M; Maiorino F; Signoretti M; Petta F; Travaglia S; Panei M; Bove P
    BJU Int; 2023 Jul; 132(1):100-108. PubMed ID: 36917033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transperineal Laser Ablation Treatment for Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction: Protocol for a Prospective In Vivo Pilot Study.
    van Kollenburg RAA; van Riel LAMJG; Bloemen PR; Oddens JR; de Reijke TM; Beerlage HP; de Bruin DM
    JMIR Res Protoc; 2020 Jan; 9(1):e15687. PubMed ID: 31961326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robot-assisted simple prostatectomy for treatment of lower urinary tract symptoms secondary to benign prostatic enlargement: surgical technique and outcomes in a high-volume robotic centre.
    Pokorny M; Novara G; Geurts N; Dovey Z; De Groote R; Ploumidis A; Schatteman P; de Naeyer G; Mottrie A
    Eur Urol; 2015 Sep; 68(3):451-7. PubMed ID: 25887786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic hyperplasia: 12-month clinical outcomes of a phase I study.
    Viitala A; Anttinen M; Wright C; Virtanen I; Mäkelä P; Hovinen T; Sainio T; Saunavaara J; Taimen P; Blanco Sequeiros R; Boström PJ
    BJU Int; 2022 Feb; 129(2):208-216. PubMed ID: 34161649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thulium laser transurethral vaporesection versus transurethral resection of the prostate for benign prostatic obstruction: the UNBLOCS RCT.
    Worthington J; Lane JA; Taylor H; Young G; Noble SM; Abrams P; Ahern A; Brookes ST; Cotterill N; Johnson L; Khan R; Fernandez AM; Page T; Swami S; Hashim H
    Health Technol Assess; 2020 Sep; 24(41):1-96. PubMed ID: 32901611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(17):1-121. PubMed ID: 23074487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience.
    Gilling P; Reuther R; Kahokehr A; Fraundorfer M
    BJU Int; 2016 Jun; 117(6):923-9. PubMed ID: 26477826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Operative profile, safety and functional outcomes after GreenLight laser prostate surgery: results from a 12 months follow-up multicenter Italian cohort analyses.
    Reale G; Marchioni M; Altieri V; Greco F; De Nunzio C; Destefanis P; Ricciardulli S; Bergamaschi F; Fasolis G; Varvello F; Voce S; Palmieri F; Divan C; Malossini G; Oriti R; Tuccio A; Ruggera L; Tubaro A; Delicato G; Laganà A; Dadone C; De Rienzo G; Ditonno A; Frattini A; Pucci L; Carrino M; Montefiore F; Germani S; Miano R; Schips L; Rabito S; Ferrari G; Cindolo L
    Minerva Urol Nefrol; 2020 Oct; 72(5):622-628. PubMed ID: 32284526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy using a low-powered holmium laser for enucleation of the prostate (HoLEP): 12-month results from a prospective low-power HoLEP series.
    Becker B; Gross AJ; Netsch C
    World J Urol; 2018 Mar; 36(3):441-447. PubMed ID: 29275506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Prostate Artery Embolization on Different Qualities of Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction.
    Theurich AT; Leistritz L; Leucht K; Franiel T; Teichgräber U; Foller S; Grimm MO
    Eur Urol Focus; 2022 Sep; 8(5):1323-1330. PubMed ID: 35125344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three years outcomes of transperineal laser ablation of the prostate.
    Minafra P; DE Rienzo G; Gerbasi S; Cindolo L; Battaglia M; Ditonno P
    Minerva Urol Nephrol; 2023 Aug; 75(4):471-478. PubMed ID: 37314812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound-guided SoracteLite™ transperineal laser ablation (TPLA) of the prostate for the treatment of symptomatic benign prostatic hyperplasia (BPH): a prospective single-center experience.
    Laganà A; Di Lascio G; Di Blasi A; Licari LC; Tufano A; Flammia RS; De Carolis A
    World J Urol; 2023 Apr; 41(4):1157-1162. PubMed ID: 36853444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomized trial comparing thulium vapoenucleation with holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic obstruction: perioperative safety and efficacy.
    Netsch C; Becker B; Tiburtius C; Moritz C; Becci AV; Herrmann TRW; Gross AJ
    World J Urol; 2017 Dec; 35(12):1913-1921. PubMed ID: 28698991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia: A Feasibility Study.
    Patelli G; Ranieri A; Paganelli A; Mauri G; Pacella CM
    Cardiovasc Intervent Radiol; 2017 Sep; 40(9):1440-1446. PubMed ID: 28474112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waterjet Ablation Therapy for Treating Benign Prostatic Obstruction in Patients with Small- to Medium-size Glands: 12-month Results of the First French Aquablation Clinical Registry.
    Misrai V; Rijo E; Zorn KC; Barry-Delongchamps N; Descazeaud A
    Eur Urol; 2019 Nov; 76(5):667-675. PubMed ID: 31281024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
    Porpiglia F; Fiori C; Bertolo R; Garrou D; Cattaneo G; Amparore D
    BJU Int; 2015 Aug; 116(2):278-87. PubMed ID: 25382816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility, safety, and efficacy of ultrasound-guided transperineal laser ablation for the treatment of benign prostatic hyperplasia: a single institutional experience.
    Frego N; Saita A; Casale P; Diana P; Contieri R; Avolio PP; Lazzeri M; Hurle R; Buffi NM; Guazzoni GF; Lughezzani G
    World J Urol; 2021 Oct; 39(10):3867-3873. PubMed ID: 33811512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT.
    Lewis AL; Young GJ; Selman LE; Rice C; Clement C; Ochieng CA; Abrams P; Blair PS; Chapple C; Glazener CM; Horwood J; McGrath JS; Noble S; Taylor GT; Lane JA; Drake MJ
    Health Technol Assess; 2020 Sep; 24(42):1-122. PubMed ID: 32902375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.